CG
LJPC

Cutler Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cutler Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed – – 5226
2020
Q1 		$0 Buy
+100
New +$632 ﹤0.01% 5082
2019
Q4 		– Sell
-700
Closed -$4.13K – 5017
2019
Q3 		$6K Buy
+700
New +$6.61K ﹤0.01% 2975
2018
Q3 		– Sell
-2,200
Closed -$64K – 5153
2018
Q2 		$64K Buy
2,200
+1,940
+746% +$59.9K 0.01% 1456
2018
Q1 		$7K Sell
260
-15,469
-98% -$499K ﹤0.01% 3129
2017
Q4 		$506K Buy
15,729
+1,916
+14% +$62.6K 0.02% 542
2017
Q3 		$480K Buy
13,813
+5,813
+73% +$187K 0.02% 683
2017
Q2 		$238K Buy
8,000
+3,420
+75% +$98K 0.01% 1156
2017
Q1 		$136K Buy
4,580
+32
+0.7% +$817 0.01% 1481
2016
Q4 		$79K Sell
4,548
-3,668
-45% -$70.3K ﹤0.01% 2124
2016
Q3 		$195K Buy
8,216
+1,516
+23% +$28.6K 0.01% 1242
2016
Q2 		$107K Buy
6,700
+5,500
+458% +$98.7K 0.01% 1633
2016
Q1 		$25K Sell
1,200
-320
-21% -$5.71K ﹤0.01% 3077
2015
Q4 		$41K Buy
+1,520
New +$41.4K ﹤0.01% 2689

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cutler Group's LJPC Position: Q2 2020 in Review

Cutler Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 100 shares.

Cutler Group first reported a position in LJPC in Q4 2015 and held it in 13 quarters. The position peaked at $506K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Cutler Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 100 La Jolla Pharmaceutical Company shares in Q2 2020.
  • Cutler Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 13 quarters.
  • Cutler Group's La Jolla Pharmaceutical Company position peaked at $506K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.